Intuitive Surgical, Inc. (FRA:IUI1)

Market Cap	151.94B -24.9%
Revenue (ttm)	8.57B +20.5%
Net Income	2.43B +23.0%
EPS	6.70 +22.6%
Shares Out	n/a
PE Ratio	62.46
Forward PE	49.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15
Average Volume	100
Open	423.05
Previous Close	423.00
Day's Range	419.75 - 426.65
52-Week Range	362.70 - 585.90
Beta	n/a
RSI	48.14
Earnings Date	Apr 14, 2026

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1995
• Employees: 17,021
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: IUI1

Financial Performance

In 2025, Intuitive Surgical's revenue was $10.06 billion, an increase of 20.51% compared to the previous year's $8.35 billion. Earnings were $2.86 billion, an increase of 22.97%.

Financial numbers in USD